Stem Cell Rev Rep January 2022 PMID 34532844

Review of the Current Trends in Clinical Trials Involving Induced Pluripotent Stem Cells.

Jennifer Yejean Kim, Yoojun Nam, Yeri Alice Rim, Ji Hyeon Ju

Download social card

Mentions

6
Peak: 2 in Mar 2025
across 3 sources since Sep 2022

Extended reach

356,002
potential audience

Total likes

9,672

Video views

353,144

Mentions per month

Sep 2022 – Mar 2025

Where it's discussed

  • X / Twitter3 posts
  • YouTube2 videos
  • News1 articles

AI synopsis

What people are saying

The discussion centers around the fascinating potential of stem cells and cloning, with followers sharing links to videos like 'Is Human Cloning Possible?,' indicating curiosity rather than critical evaluation. The tone is speculative and intrigued, which aligns with the interest level but indicates limited in-depth engagement or impact on scientific discourse.

AgreementNeither agree nor disagree

The posts do not explicitly agree or disagree with the publication's findings, rather they seem more like curiosity or exploratory questions about stem cells and cloning.

InterestModerate interest

There is a mild interest in the topic, likely due to the intriguing possibility of human cloning and stem cell applications, but the posts do not delve deeply into the research details.

EngagementLow engagement

The discussion appears superficial, with references to videos and general questions rather than analytical engagement or critical discussion about the article's content.

ImpactNeutral impact

The social discussions do not seem to influence opinions or prompt significant debates; they are more about sparking curiosity than impactful dialogue.

Abstract in brief

  • Since their introduction in 2006, induced pluripotent stem cells (iPSCs) have shown great potential for developing new treatments for many diseases, but few clinical trials have made it into actual therapies.
  • The review found that the United States mainly conducts nontherapeutic trials with many participants, especially focusing on circulatory system disorders, while Japan leads in therapeutic trials with smaller groups, often targeting disorders of the circulatory, nervous, and visual systems.
  • Overall, the review highlights the growing importance and potential of iPSC-based therapies, emphasizing the need for increased development and tracking of global clinical trials to advance these innovative treatments.

Top posts

Most liked on X and Bluesky
TRUTH
@ClearBlueRain · X

✨DNAndrea✨ Is Human Cloning Possible? | The Power of Stem Cells https://t.co/ULvoV3HJY7

Mar 30, 2025 · 1 share · 2,837 followers View post →
Kyohei Kubori
@GRIT91925483 · X

Is Human Cloning Possible? | The Power of Stem Cells https://t.co/s5j0O1aOEZ @YouTubeより

May 21, 2023 · 5 followers View post →

All mentions

Johnny
@Johnny343586835 · X

RT @ClearBlueRain: ✨DNAndrea✨ Is Human Cloning Possible? | The Power of Stem Cells https://t.co/ULvoV3HJY7

Mar 30, 2025 · 1 share · 3 followers View post →
TRUTH
@ClearBlueRain · X

✨DNAndrea✨ Is Human Cloning Possible? | The Power of Stem Cells https://t.co/ULvoV3HJY7

Mar 30, 2025 · 1 share · 2,837 followers View post →
Kyohei Kubori
@GRIT91925483 · X

Is Human Cloning Possible? | The Power of Stem Cells https://t.co/s5j0O1aOEZ @YouTubeより

May 21, 2023 · 5 followers View post →
Long-term Culture of Skin Biopsies Maintenance of | PDF | Wound ...
News

doi:10.1007/S12015-021-10262-3 31. Zushin PJH, Mukherjee S, Wu JC. FDA Modernization Act 2.0: transitioning beyond animal models with human cells, organoids ...

Dec 14, 2025 View →